| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2879692 | The Annals of Thoracic Surgery | 2008 | 6 Pages |
Abstract
OPCAB showed better clinical outcome in 12-month and cumulative MACCE rate in 3-vessel coronary artery diseases. The major factor for the difference was target vessel revascularization. Longer follow-up is needed to clarify the differences between the two groups.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Gijong MD, Young-Nam MD, Kyung-Jong MD, PhD, You-Sun MD,